NovaBridge Biosciences (NBP) Inventory (2021 - 2023)

NovaBridge Biosciences (NBP) has 3 years of Inventory data on file, last reported at $718742.3 in Q4 2023.

• Quarterly Inventory fell 84.49% year-over-year to $718742.3 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $718742.3 (down 84.49% YoY) and the FY2023 annual result came in at $729000.0, down 84.75% from the prior year.
• Inventory retreated to $718742.3 in Q4 2023 per NBP's latest filing, from $4.6 million in the prior quarter.
• Across five years, Inventory topped out at $4.3 billion in Q4 2021 and bottomed at $718742.3 in Q4 2023.
• The 3-year median for Inventory is $4.4 million (2022), against an average of $1.1 billion.
• The widest annual swing landed in 2022, when Inventory plunged 99.89%; it then tumbled 84.49% in 2023.
• Tracing NBP's Inventory over 3 years: stood at $4.3 billion in 2021, then sank by 99.89% to $4.6 million in 2022, then plunged by 84.49% to $718742.3 in 2023.
• Per Business Quant, the three latest NBP Inventory figures stand at $718742.3 (Q4 2023), $4.6 million (Q4 2022), and $4.1 million (Q2 2022).

Peer Comparison